title: A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the "Back of the Line" as a therapy for dyslipidemia?
authors.affiliation: Sterling Rock Falls Clinic, 101 East Miller Road, Sterling, IL 61081, USA.
authors.forename: Peter P
authors.initials: PP
authors.lastname: Toth
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Maki